Stock A115180 QURIENT CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Qurient Co., Ltd.

Equities

A115180

KR7115180002

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-06-27 EDT 		5-day change 1st Jan Change
3,550 KRW -1.39% Intraday chart for Qurient Co., Ltd. -4.70% -23.98%
05-21 Qurient Therapeutics Enters CRADA with the National Cancer Institute to Collaborate on a Phase 1/2 Clinical Study of Q901 in Combination with TROP2-ADC CI
05-17 Qurient Co., Ltd. announced that it has received KRW 13.499996307 billion in funding from DongKoo Bio & Pharma Co., Ltd. CI

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A115180 Stock
  4. News Qurient Co., Ltd.
  5. Analyst Reco.